Week in review: Dry-eye venture, orphan drugs, quality control

This week, Aerie Pharmaceuticals expands into the dry eye space, two ophthalmic drugs snag orphan drug designations and NEI researchers unveil an AI-based system to screen stem cell-derived retinal tissues.
Source: AAO

Posted in: Uncategorized

Leave a response

658 Malta Ave, Suite 101 Malta, NY 12020 (518) 580-0553